EMBECTA CORP. Diluted Shares Outstanding (Weighted Average)
EMBECTA CORP. (EMBC) reported Diluted Shares Outstanding (Weighted Average) of 58.51 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-07
- EMBECTA CORP. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 58.51M shares, a 0.03% increase year-over-year.
- EMBECTA CORP. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 59.30M shares, a 1.28% increase year-over-year.
- EMBECTA CORP. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 59.29M shares, a 1.14% increase year-over-year.
- EMBECTA CORP. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 59.50M shares, a 1.06% increase year-over-year.
- EMBECTA CORP. weighted average number of shares outstanding, diluted for fiscal 2025 was 58.91M shares, a 1.01% increase from fiscal 2024.
- EMBECTA CORP. weighted average number of shares outstanding, diluted for fiscal 2024 was 58.33M shares, a 0.98% increase from fiscal 2023.
- EMBECTA CORP. weighted average number of shares outstanding, diluted for fiscal 2023 was 57.76M shares, a 0.52% increase from fiscal 2022.
- EMBECTA CORP. weighted average number of shares outstanding, diluted for fiscal 2022 was 57.46M shares, a 0.79% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 58.51M shares 10-Q · filed 2026-08-07 | 58.91M shares derived: average of 2 quarters · filed 2026-08-07 | 59.58M shares 10-Q · filed 2026-08-07 | 59.15M shares derived: average of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | 59.30M shares 10-Q · filed 2026-05-05 | 59.73M shares 10-Q · filed 2026-05-05 | 59.36M shares derived: average of 3 quarters · filed 2026-05-05 | 59.15M shares derived: average of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | 59.29M shares 10-Q · filed 2026-02-05 | 59.39M shares derived: average of 2 quarters · filed 2026-02-05 | 59.09M shares derived: average of 3 quarters · filed 2026-08-07 | 58.96M shares derived: average of 4 quarters · filed 2026-08-07 | ||
| 2025-09-30 | 59.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | 59.00M shares derived: average of 2 quarters · filed 2026-08-07 | 58.85M shares derived: average of 3 quarters · filed 2026-08-07 | 58.91M shares 10-K · filed 2025-11-25 | ||
| 2025-06-30 | 58.49M shares 10-Q · filed 2026-08-07 | 58.52M shares derived: average of 2 quarters · filed 2026-08-07 | 58.72M shares 10-Q · filed 2026-08-07 | 58.63M shares derived: average of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | 58.55M shares 10-Q · filed 2026-05-05 | 58.66M shares 10-Q · filed 2026-05-05 | 58.68M shares derived: average of 3 quarters · filed 2026-05-05 | 58.47M shares derived: average of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | 58.62M shares 10-Q · filed 2026-02-05 | 58.75M shares derived: average of 2 quarters · filed 2026-02-05 | 58.45M shares derived: average of 3 quarters · filed 2026-02-05 | 58.29M shares derived: average of 4 quarters · filed 2026-02-05 | ||
| 2024-09-30 | 58.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | 58.36M shares derived: average of 2 quarters · filed 2025-11-25 | 58.17M shares derived: average of 3 quarters · filed 2025-11-25 | 58.33M shares 10-K · filed 2025-11-25 | ||
| 2024-06-30 | 57.84M shares 10-Q · filed 2025-08-08 | 57.82M shares derived: average of 2 quarters · filed 2025-08-08 | 58.14M shares 10-Q · filed 2025-08-08 | 57.79M shares derived: average of 4 quarters · filed 2025-11-25 | ||
| 2024-03-31 | 57.81M shares 10-Q · filed 2025-05-09 | 57.98M shares 10-Q · filed 2025-05-09 | 57.78M shares derived: average of 3 quarters · filed 2025-11-25 | 57.73M shares derived: average of 4 quarters · filed 2025-11-25 | ||
| 2023-12-31 | 57.63M shares 10-Q · filed 2025-02-06 | 57.76M shares derived: average of 2 quarters · filed 2025-11-25 | 57.70M shares derived: average of 3 quarters · filed 2025-11-25 | 57.65M shares derived: average of 4 quarters · filed 2025-11-25 | ||
| 2023-09-30 | 57.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | 57.74M shares derived: average of 2 quarters · filed 2025-11-25 | 57.66M shares derived: average of 3 quarters · filed 2025-11-25 | 57.76M shares 10-K · filed 2025-11-25 | ||
| 2023-06-30 | 57.58M shares 10-Q · filed 2024-08-09 | 57.55M shares derived: average of 2 quarters · filed 2024-08-09 | 57.71M shares 10-Q · filed 2024-08-09 | 56.95M shares derived: average of 4 quarters · filed 2024-12-11 | ||
| 2023-03-31 | 57.51M shares 10-Q · filed 2024-05-09 | 57.61M shares 10-Q · filed 2024-05-09 | 56.74M shares derived: average of 3 quarters · filed 2024-12-11 | 57.11M shares derived: average of 4 quarters · filed 2024-12-11 | ||
| 2022-12-31 | 57.48M shares 10-Q · filed 2024-02-09 | 56.36M shares derived: average of 2 quarters · filed 2024-12-11 | 56.97M shares derived: average of 3 quarters · filed 2024-12-11 | 57.18M shares derived: average of 4 quarters · filed 2024-12-11 | ||
| 2022-09-30 | 55.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | 56.72M shares derived: average of 2 quarters · filed 2024-12-11 | 57.08M shares derived: average of 3 quarters · filed 2024-12-11 | 57.46M shares 10-K · filed 2024-12-11 | ||
| 2022-06-30 | 58.21M shares 10-Q · filed 2023-08-08 | 58.00M shares derived: average of 2 quarters · filed 2023-08-08 | 58.20M shares 10-Q · filed 2023-08-08 | 56.92M shares derived: average of 4 quarters · filed 2023-11-29 | ||
| 2022-03-31 | 57.80M shares 10-Q · filed 2023-05-12 | 57.80M shares 10-Q · filed 2022-05-13 | 57.80M shares 10-Q · filed 2023-05-12 | 57.80M shares 10-Q · filed 2022-05-13 | 56.49M shares derived: average of 3 quarters · filed 2023-11-29 | 56.82M shares derived: average of 4 quarters · filed 2023-11-29 |
| 2021-12-31 | 57.01M shares 10-Q · filed 2023-02-14 | 55.84M shares derived: average of 2 quarters · filed 2023-11-29 | 56.49M shares derived: average of 3 quarters · filed 2023-11-29 | 56.82M shares derived: average of 4 quarters · filed 2023-11-29 | ||
| 2021-09-30 | 54.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | 56.23M shares derived: average of 2 quarters · filed 2023-11-29 | 56.75M shares derived: average of 3 quarters · filed 2023-11-29 | 57.01M shares 10-K · filed 2023-11-29 | ||
| 2021-06-30 | 57.80M shares 10-Q · filed 2022-08-15 | 57.80M shares derived: average of 2 quarters · filed 2022-08-15 | 57.80M shares 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | 57.80M shares 10-Q · filed 2022-05-13 | 57.80M shares 10-Q · filed 2022-05-13 | ||||
| 2020-09-30 | 57.01M shares 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |